CytoDyn Inc. Financial and Nonfinancial Liabilities, Fair Value Disclosure
CytoDyn Inc. (CYDY) had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $0 as of 2021-11-30, per its 10-Q filed 2022-01-10.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2022-01-10
- 2021-11-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2021-08-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2021-05-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
- 2020-05-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $0.00.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2021-11-30 | $0.00 10-Q · filed 2022-01-10 |
| 2021-08-31 | $0.00 10-Q · filed 2021-10-12 |
| 2021-05-31 | $0.00 10-Q · filed 2022-01-10 |
| 2020-05-31 | $0.00 10-K · filed 2020-08-14 |
| 2020-02-29 | $2.11M 10-Q · filed 2020-04-09 |
| 2019-11-30 | $1.58M 10-Q · filed 2020-01-09 |
| 2019-08-31 | $1.78M 10-Q · filed 2019-10-08 |
| 2019-05-31 | $2.41M 10-K · filed 2020-08-14 |
| 2019-02-28 | $3.19M 10-Q · filed 2019-04-09 |
| 2018-11-30 | $3.08M 10-Q · filed 2019-01-09 |
| 2018-08-31 | $2.07M 10-Q · filed 2018-10-09 |
| 2018-05-31 | $1.32M 10-K · filed 2019-08-14 |
| 2017-05-31 | $3.01M 10-K · filed 2018-07-27 |